Booked 6.7 Billion Yen Special Loss In Q3 Due To Termination Of Norovirus Vaccine Development At German Subsidiary Icon Genetics
07/02/2024 02:03
Denka Co Ltd 4061.T :
* DENKA CO LTD - BOOKED 6.7 BILLION YEN SPECIAL LOSS IN Q3
DUE TO
TERMINATION OF NOROVIRUS VACCINE DEVELOPMENT AT GERMAN
SUBSIDIARY ICON GENETICS
Source text for Eikon: ID:nTSng80cfe
Further company coverage: 4061.T